Update on the management of acute heart failureRayner-Hartley, Erin; Virani, Sean; Toma, MustafaCurrent Opinion in Cardiology: March 2018 - Volume 33 - Issue 2 - p 225–231 doi: 10.1097/HCO.0000000000000485 HEART FAILURE: Edited by Haissam Haddad Abstract Author InformationAuthors Article MetricsMetrics Purpose of review We provide a concise review of recent studies focusing on the management of patients with acute heart failure (AHF). Recent findings In well designed randomized trials, no mortality benefit has been observed with the use of diuretics, ultrafiltration, inotropes and vasodilators in AHF. Recent trials examining the role of novel inotropes and vasodilators as well as the role of mineralocorticoid receptor antagonists in the AHF population, is reviewed. Summary The focus of therapy in AHF should be directed towards symptom management. No mortality benefit has been observed despite good quality studies. Division of Cardiology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada Correspondence to Dr Mustafa Toma, MD, Division of Cardiology, St. Paul's Hospital, 475A-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada. Tel: +1 604 806 9986; e-mail: MToma@providencehealth.bc.ca Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.